메뉴 건너뛰기




Volumn 24, Issue 4, 2007, Pages 272-277

In vitro activity of amphotericin B and anidulafungin against Candida spp. biofilms;Actividad in vitro de la anfotericina B y la anidulafungina sobre biopelículas de Candida albicans y Candida tropicalis

Author keywords

Amphotericin B; Anidulafungin; Biofilms; Candida albicans; Candida tropicalis

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN;

EID: 38349158395     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1130-1406(07)70055-4     Document Type: Article
Times cited : (28)

References (45)
  • 4
    • 0034870709 scopus 로고    scopus 로고
    • Biofilm formation by the fungal pathogen Candida albicans: Development, architecture, and drug resistance
    • Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA. Biofilm formation by the fungal pathogen Candida albicans: Development, architecture, and drug resistance. J Bacteriol 2001; 183: 5385-5394.
    • (2001) J Bacteriol , vol.183 , pp. 5385-5394
    • Chandra, J.1    Kuhn, D.M.2    Mukherjee, P.K.3    Hoyer, L.L.4    McCormick, T.5    Ghannoum, M.A.6
  • 5
    • 33846014067 scopus 로고    scopus 로고
    • Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved standard
    • Clinical and Laboratory Standards Institute, 2 nd ed, Wayne, PA
    • nd ed. CLSI document M27-A2. Wayne, PA, 2002.
    • (2002) CLSI document
  • 6
    • 24644448753 scopus 로고    scopus 로고
    • Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms
    • Cocuaud C, Rodier M-H, Daniault G, Imbert C. Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms. J Antimicrob Chemother 2005; 56: 507-512.
    • (2005) J Antimicrob Chemother , vol.56 , pp. 507-512
    • Cocuaud, C.1    Rodier, M.-H.2    Daniault, G.3    Imbert, C.4
  • 7
    • 33750577895 scopus 로고    scopus 로고
    • In vitro Pharmacodynamics of anidulafungin and caspofungin against Candida glabrata isolates, including strains with decreased caspofungin susceptibility
    • Cota J, Carden M, Graybill JR, Najvar LK, Burgess DS, Wiederhold NP. In vitro Pharmacodynamics of anidulafungin and caspofungin against Candida glabrata isolates, including strains with decreased caspofungin susceptibility. Antimicrob Agents Chemother 2006; 50: 3926-3928.
    • (2006) Antimicrob Agents Chemother , vol.50 , pp. 3926-3928
    • Cota, J.1    Carden, M.2    Graybill, J.R.3    Najvar, L.K.4    Burgess, D.S.5    Wiederhold, N.P.6
  • 8
    • 0033591467 scopus 로고    scopus 로고
    • Bacterial biofilms: A common cause of persistent infections
    • Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: A common cause of persistent infections. Science 1999; 284: 1318-1322.
    • (1999) Science , vol.284 , pp. 1318-1322
    • Costerton, J.W.1    Stewart, P.S.2    Greenberg, E.P.3
  • 10
    • 0035887796 scopus 로고    scopus 로고
    • Biofilm formation: A clinically relevant microbiological process
    • Donlan RM. Biofilm formation: A clinically relevant microbiological process. Clin Infect Dis 2001; 33: 1387-1392.
    • (2001) Clin Infect Dis , vol.33 , pp. 1387-1392
    • Donlan, R.M.1
  • 11
    • 0036228505 scopus 로고    scopus 로고
    • Biofilms: Survival mechanisms of clinically relevant microorganisms
    • Donlan RM, Costerton W. Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002; 15: 167-193.
    • (2002) Clin Microbiol Rev , vol.15 , pp. 167-193
    • Donlan, R.M.1    Costerton, W.2
  • 12
    • 0036711963 scopus 로고    scopus 로고
    • Biofilms: Microbial life on surfaces
    • Donlan RM. Biofilms: Microbial life on surfaces. Emerg Infect Dis 2002; 8: 881-890.
    • (2002) Emerg Infect Dis , vol.8 , pp. 881-890
    • Donlan, R.M.1
  • 13
    • 0036756090 scopus 로고    scopus 로고
    • Medical importance of biofilms in Candida infections
    • Douglas LJ. Medical importance of biofilms in Candida infections. Rev Iberoam Micol 2002; 19: 139-143.
    • (2002) Rev Iberoam Micol , vol.19 , pp. 139-143
    • Douglas, L.J.1
  • 16
    • 0027976646 scopus 로고
    • Biofilm formation by Candida species on the surface of catheter materials in vitro
    • Hawser SP, Douglas LJ. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect. Inmun 1994; 62: 915-821.
    • (1994) Infect. Inmun , vol.62 , pp. 915-821
    • Hawser, S.P.1    Douglas, L.J.2
  • 17
    • 0029135076 scopus 로고
    • Resistance of Candida albicans biofilms to antifungal agents in vitro
    • Hawser SP, Douglas LJ. Resistance of Candida albicans biofilms to antifungal agents in vitro. Antimicrob Agents Chemother 1995; 39: 2128-2131.
    • (1995) Antimicrob Agents Chemother , vol.39 , pp. 2128-2131
    • Hawser, S.P.1    Douglas, L.J.2
  • 18
    • 0031980747 scopus 로고    scopus 로고
    • Comparison of a 2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(Phenyl-amino) carboxyl]-2 H-tetrazolium hydroxide (XTT) colorimetric mehod with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents
    • Hawser SP, Norris H, Jessup CJ, Ghannoum MA. Comparison of a 2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(Phenyl-amino) carboxyl]-2 H-tetrazolium hydroxide (XTT) colorimetric mehod with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents. J Clin Microbiol 1998; 36: 1450-1452.
    • (1998) J Clin Microbiol , vol.36 , pp. 1450-1452
    • Hawser, S.P.1    Norris, H.2    Jessup, C.J.3    Ghannoum, M.A.4
  • 19
    • 0038168441 scopus 로고    scopus 로고
    • Biofilm-forming ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection
    • Jin Y, Yip HK, Samaranayake YH, Yau JY, Samaranayake LP. Biofilm-forming ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection. J Clin Microbiol 2003; 41: 2961-2967.
    • (2003) J Clin Microbiol , vol.41 , pp. 2961-2967
    • Jin, Y.1    Yip, H.K.2    Samaranayake, Y.H.3    Yau, J.Y.4    Samaranayake, L.P.5
  • 20
    • 85088684979 scopus 로고    scopus 로고
    • th International Congress of Chemotherapy (ICC). Munich, 2007.
    • th International Congress of Chemotherapy (ICC). Munich, 2007.
  • 21
    • 2042519310 scopus 로고    scopus 로고
    • Candida infections of medical devices
    • Kojic EM, Darouiche RO. Candida infections of medical devices. Clin Microbiol Rev 2004; 17: 255-267.
    • (2004) Clin Microbiol Rev , vol.17 , pp. 255-267
    • Kojic, E.M.1    Darouiche, R.O.2
  • 22
    • 0036151240 scopus 로고    scopus 로고
    • Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces
    • Kuhn DM, Chandra J, Mukherjee PK, Ghannoum MA. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Inmun 2002; 70: 878-888.
    • (2002) Infect Inmun , vol.70 , pp. 878-888
    • Kuhn, D.M.1    Chandra, J.2    Mukherjee, P.K.3    Ghannoum, M.A.4
  • 23
    • 0036096359 scopus 로고    scopus 로고
    • Antifungal susceptibility of Candida biofilms: Unique efficacy of amphotericin B lipid formulations and echinocandins
    • Kuhn DM, Chandra J, Mukherjee PK, Ghannoum MA. Antifungal susceptibility of Candida biofilms: Unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 2002; 46: 1773-1780.
    • (2002) Antimicrob Agents Chemother , vol.46 , pp. 1773-1780
    • Kuhn, D.M.1    Chandra, J.2    Mukherjee, P.K.3    Ghannoum, M.A.4
  • 24
    • 27144503650 scopus 로고    scopus 로고
    • Alternative Candida albicans lifestyles: Growth on surfaces
    • Kumamoto CA, Vinces MD. Alternative Candida albicans lifestyles: growth on surfaces. Annu Rev Microbiol 2005; 59: 113-133.
    • (2005) Annu Rev Microbiol , vol.59 , pp. 113-133
    • Kumamoto, C.A.1    Vinces, M.D.2
  • 25
    • 0041764578 scopus 로고    scopus 로고
    • Mechanism of fluconazole resistance in Candida albicans biofilms: Phase-specific role of efflux pumps and membrane sterols
    • Mukherjee RK, Chandra J, Kuhn D.M, Ghannoum M.A. Mechanism of fluconazole resistance in Candida albicans biofilms: Phase-specific role of efflux pumps and membrane sterols. Infect Inmun 2003; 71: 4333-4340.
    • (2003) Infect Inmun , vol.71 , pp. 4333-4340
    • Mukherjee, R.K.1    Chandra, J.2    Kuhn, D.M.3    Ghannoum, M.A.4
  • 27
    • 0037407952 scopus 로고    scopus 로고
    • To build a biofilm
    • O'Toole GA. To build a biofilm. J Bacteriol 2003; 185: 2687-2689.
    • (2003) J Bacteriol , vol.185 , pp. 2687-2689
    • O'Toole, G.A.1
  • 29
    • 0242523776 scopus 로고    scopus 로고
    • Bacterial biofilms: An emerging link to disease pathogenesis
    • Parsek MR, Singh PK. Bacterial biofilms: An emerging link to disease pathogenesis. Annu Rev Microbiol 2003; 57: 677-701.
    • (2003) Annu Rev Microbiol , vol.57 , pp. 677-701
    • Parsek, M.R.1    Singh, P.K.2
  • 30
    • 0035431077 scopus 로고    scopus 로고
    • Biofilms of Candida albicans and their associated resistance to antifungal agents
    • Ramage G, Wickes BL, López-Ribot JL. Biofilms of Candida albicans and their associated resistance to antifungal agents. Am Clin Lab 2001; 20: 42-44.
    • (2001) Am Clin Lab , vol.20 , pp. 42-44
    • Ramage, G.1    Wickes, B.L.2    López-Ribot, J.L.3
  • 32
    • 0034863427 scopus 로고    scopus 로고
    • Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms
    • Ramage G, VandeWalle K, Wickes BL, López-Ribot JL. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother 2001; 45: 2475-2479.
    • (2001) Antimicrob Agents Chemother , vol.45 , pp. 2475-2479
    • Ramage, G.1    VandeWalle, K.2    Wickes, B.L.3    López-Ribot, J.L.4
  • 33
    • 0035992139 scopus 로고    scopus 로고
    • Investigation of multidrug efflux pumps in relation to fluconazol resistance in Candida albicans biofilms
    • Ramage G, Bachmann S, Patterson TF, Wickes BJ, López-Ribot JL. Investigation of multidrug efflux pumps in relation to fluconazol resistance in Candida albicans biofilms. J Antimicrob Chemoter 2002; 49: 973-980.
    • (2002) J Antimicrob Chemoter , vol.49 , pp. 973-980
    • Ramage, G.1    Bachmann, S.2    Patterson, T.F.3    Wickes, B.J.4    López-Ribot, J.L.5
  • 38
    • 33751182110 scopus 로고    scopus 로고
    • In vitro effects of micafungin against Candida biofilms on polystyrene and central venous catheter sections
    • Seidler M, Salvenmoser S, Müller F-MC. In vitro effects of micafungin against Candida biofilms on polystyrene and central venous catheter sections. Int J Antimicrob Agents 2006; 28: 568-573.
    • (2006) Int J Antimicrob Agents , vol.28 , pp. 568-573
    • Seidler, M.1    Salvenmoser, S.2    Müller, F.-M.C.3
  • 39
    • 33748035709 scopus 로고    scopus 로고
    • Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model
    • Shuford JA, Rouse MS, Piper KE, Steckelberg JM, Patel R. Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model. J Infect Dis 2006; 194: 710-713.
    • (2006) J Infect Dis , vol.194 , pp. 710-713
    • Shuford, J.A.1    Rouse, M.S.2    Piper, K.E.3    Steckelberg, J.M.4    Patel, R.5
  • 40
    • 33847255390 scopus 로고    scopus 로고
    • In vitro biofilm characterization and activity of antifungal agents alone and in combination against sessile cells and planktonic clinical isolates
    • Shuford JA, Piper KE, Steckelberg JM, Patel R. In vitro biofilm characterization and activity of antifungal agents alone and in combination against sessile cells and planktonic clinical isolates. Diag Microbiol Infect Dis 2007; 57: 277-281.
    • (2007) Diag Microbiol Infect Dis , vol.57 , pp. 277-281
    • Shuford, J.A.1    Piper, K.E.2    Steckelberg, J.M.3    Patel, R.4
  • 42
    • 0026647746 scopus 로고
    • Innovative endpoint determination system for antifungal susceptibility testing of yeasts
    • Tellier R, Krajden M, Grigoriew A, Campbell I. Innovative endpoint determination system for antifungal susceptibility testing of yeasts. Antimicrob Agents Chemother 1992; 36: 1619-1625.
    • (1992) Antimicrob Agents Chemother , vol.36 , pp. 1619-1625
    • Tellier, R.1    Krajden, M.2    Grigoriew, A.3    Campbell, I.4
  • 43
    • 27144450690 scopus 로고    scopus 로고
    • The European Confederation of Medical Mycology (ECMN) survey of candidaemia in Italy: In vitro susceptibility of 375 Candida albicans isolates and biofilm production
    • Tortorano AM, Prigitano A, Biraghi E, Viviani MA. The European Confederation of Medical Mycology (ECMN) survey of candidaemia in Italy: in vitro susceptibility of 375 Candida albicans isolates and biofilm production. J Antimicrob Chemother 2005; 56: 777-779.
    • (2005) J Antimicrob Chemother , vol.56 , pp. 777-779
    • Tortorano, A.M.1    Prigitano, A.2    Biraghi, E.3    Viviani, M.A.4
  • 44
    • 85088684332 scopus 로고    scopus 로고
    • th International Congress of Chemotherapy (ICC), Munich, 2007.
    • th International Congress of Chemotherapy (ICC), Munich, 2007.
  • 45
    • 33947648925 scopus 로고    scopus 로고
    • Anidulafungin - state of affairs from a clinical perspective
    • Vehreschild JJ, Kümmerle T, Karthaus M, Cornely OA. Anidulafungin - state of affairs from a clinical perspective. Mycoses 2007; 50(Supl. 1): 38-43.
    • (2007) Mycoses , vol.50 , Issue.SUPL. 1 , pp. 38-43
    • Vehreschild, J.J.1    Kümmerle, T.2    Karthaus, M.3    Cornely, O.A.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.